FAIRCHEMOR Fairchem Organics Q3 FY25 results (Oct–Dec 2024) and concall
Fairchem Organics faced a challenging Q3 FY25 with significant declines in revenue and EBITDA, primarily due to an adverse custom duty hike on raw materials and soft demand from the paint sector. Despite these headwinds, the company is optimistic about its high-value isostearic acid product, which is export-focused and expected to drive margin recovery. Management also highlighted a strong balance sheet with no long-term debt and ongoing efforts to commercialize a new product with substantial revenue potential, albeit with a longer development timeline.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 |
|---|---|
| Revenue | 114 |
| EBITDA | 8 |
| Net profit | 4 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
